Instruction for use: Eldepryl

Dosage form: tablets

Active substance: Selegiline*

ATX

N04BD01 Selegiline

Pharmacological groups:

Dopaminomimetics

Anti-Parkinsonics

The nosological classification (ICD-10)

G20 Parkinson's disease: A trembling paralysis; Idiopathic Parkinsonism; Parkinson's disease; Symptomatic Parkinsonism

G21 Secondary Parkinsonism: Medicinal Parkinsonism; Parkinsonism; Parkinsonism symptomatic; Disorders of extrapyramidal system; Parkinson's Syndrome

Composition and release form

1 tablet contains selegiline 5 mg; In the package of 100 pcs.

Pharmachologic effect

Mode of action - antiparkinsonian.

Inhibits MAO B type and promotes an increase in the level of dopamine in the brain (by reducing its oxidation).

Indications for Eldepryl

Parkinson's disease, Parkinsonism.

Contraindications

Hypersensitivity.

Side effects

Dry mouth, insomnia, elevated ALT in serum.

Interaction

Enhances the effect of levodopa.

Dosing and Administration

Inside, for 5-10 mg in the morning.

Storage conditions of the drug Eldepryl

At room temperature.

Keep out of the reach of children.

Shelf life of the drug Eldepryl

5 years.

Do not use after the expiry date printed on the package.